A 282 million dollar grant has been approved by the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) for a malaria and tuberculosis control programme in Pakistan.
A 282 million dollar grant has been approved by the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) for a malaria and tuberculosis control programme in Pakistan.
The Global Fund’s technical review committee gave Pakistan its blessing before approving the grant, according to a spokesperson for the ministry.
The minister of national health services expressed his gratitude for the time’s cooperation from the Common Management Unit and ministry staff.
He asserted that the government would use this grant to enhance the malaria and tuberculosis control programmes in Pakistan in an effort to eradicate the diseases.
According to him, this represents a significant accomplishment because it was the first time since 2003 that Pakistan’s grant request was approved during the Global Fund’s first window. The Global Fund staff was thanked for approving this grant for Pakistan.
He also expressed gratitude to the donors who helped Pakistan obtain this grant, including UNAIDS, WHO, UNICEF, and USAID.
He claimed that the government was using all resources at its disposal to protect citizens from various diseases.
In order to “attract, leverage, and invest additional resources to end the epidemics of HIV/AIDS, tuberculosis, and malaria to support attainment of the Sustainable Development Goals established by the United Nations,” the Global Fund to Fight AIDS, Tuberculosis, and Malaria (also known as the Global Fund) is an international financing and partnership organisation.
The secretariat of this multistakeholder international organisation is located in Geneva, Switzerland and operations began in 2002. Bill Gates, the founder of Microsoft, was one of the initial donors to the partnership. Since 2006, the organisation has been granted US privileges, exemptions, and immunities under the International Organizations Immunities Act.
The Global Fund is the largest donor to worldwide initiatives for TB, AIDS, and malaria care and treatment. In 2018, it supported 18.9 million people receiving antiretroviral therapy for AIDS, 5.3 million people receiving anti-tuberculosis treatment, and the distribution of 131 million insecticide-treated nets. 32 million lives have been saved worldwide since its founding.